SLC-391

DB18814InvestigationalSmall molecule

SLC-391: Overview.

Mechanism: Pharmacologically active on Tyrosine-protein kinase receptor UFO
Curator reviewed
Formula / weight: C₁₉H₂₃N₇O · 365.441 g/mol (avg)
Code names: SLC-0211 · SLC-391

Resolves to

Compound

Structure

InChIKeyJYVSYFGHYFXYBE-UHFFFAOYSA-NSMILESNC1=NC=C(C=C1C1=NN=C(CC2CC2)O1)C1=CN(N=C1)C1CCNCC1

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with SLC-391, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.